• Lipid metabolism disorder: does it occur in healthy children and is it possible to eliminate modified risk factors?
en To content Full text of article

Lipid metabolism disorder: does it occur in healthy children and is it possible to eliminate modified risk factors?

SOVREMENNAYA PEDIATRIYA.2018.1(89):64-72; doi 10.15574/SP.2018.89.64

Kvashnina L. V., Ignatova T. B.
SI "Institute of Pediatrics, Obstetrics and Gynecology of NAMS of Ukraine", Kyiv

Objective: to study the features of lipid metabolism in healthy children of primary school age.
Material and methods. A comprehensive examination of 209 healthy children aged 619 years was carried out with the determination of the following blood values: total cholesterol, triglycerides, low-density lipoproteins, very low-density lipoproteins, high-density lipoproteins, apolipoproteins (A1 and B) and their ratio. The assessment of the body-weight index was based on the child's age and height. An assessment of the family history, physical activity, nature and nutrition regimen was conducted by using questionnaires.
Results. Different disorders of lipid metabolism were detected in 70.5% of children: the increasing of total cholesterol in blood was revealed in 41.17% of children and low-density lipoproteins – in 26.5% of cases; the reduction of high-density lipoproteins was detected in 17.6% of children, and the increased atherogenic index was found in 11.8% of cases. Hypertriglyceridaemia was determined in 20.6% of children. Different types of combined dyslipidaemia were observed in 45.5% of cases. Analysing the questionnaires, the violation of diet quality and nutrition regimen, hypodynamia, burdened family history, various functional disorders of children's health were revealed.
Conclusions. A group of healthy children of the primary schoo- age regarding the lipid metabolism has different types of dyslipidaemia. The ratio of ApoB/ApoA1 is the most informative marker for cardiovascular disorders and endothelial dysfunction. One of the cardiovascular risk factors is obesity, which was observed in 13.9% of children and overweight – in 5.6% of children. The peculiarity of lipid metabolism in this group of children was significant hypertriglyceridaemia in 15.4% of children. There was a violation of the nutrition regimen and the main ingredient balance with the significant deficit of vegetable fat intake in all examined children. The revealed changes of lipid metabolism and life peculiarities of modern schoolchildren are modified factors that contribute to the development of cardiovascular disorders and require early correction during all periods of childhood.
Key words: children, dyslipidaemia, risk factors.

References

1. Dedov II, Melnichenko GA. (2006). The obesity. An etiology, a pathogenesis, clinical aspects. The leadership for doctors. Moscow: MIA.

2. Drobyshevskaya VA. (2010). The violation of lipid exchange of patients with alimentary obesity. The problems of health and ecology. 4(26): 109–114.

3. Kvashnina LV, Ignatova TB. (2016). Prophylaxis of disturbances of endothelial function within the children during transition from health to a syndrome of vegetative dysfunction. Sovremennaya pediatriya. 5(77): 16–24. doi10.15574/SP.2016.77.16

4. Lebedkova SE, Evstifeeva GJ. (2011). The politik and strategy of preventive programs of chronic noninfectious diseases of schoolers. Pediatrics. 1; 90: 112–117.

5. Maydannikov VG, Moskalenko VF. (2007). The primary arterial hypertension among the children and teenagers. Keiv.

6. Maydannik VG, Haytovich MV, Pavlishin A et al. (2013). The prevalence of excess body weight and the increased arterial blood pressure among the schoolers in different regions of Ukraine. The International magazine of pediatrics, obstetrics and gynecology. 1; 3: 33–39.

7. Mitchenko OI, Lutay MI. (2011). The dyslipidemia: diagnostics, prevention and treatment. Methodical references of Association of cardiologists of Ukraine. Kyiv. PMid:21660390

8. Murashko EV, Stepanova NG, Perminova EV. (2007). The identification of risk group on development of cardiovascular pathology among the children during the first two years of life. The bulletin VSNC SO RAMN. 3(55): 107–108.

9. Oganov RG. (Ed.) (2009). The dyslipidemia and atherosclerosis. Мoscow: GEOTAR–Media.

10. About the approval of the standards of physiological needs of the population of Ukraine for the main feedstuffs and energy. 07.12.2017 from year. The order MOZ of Ukraine 1073. http://www.moz.gov.ua.

11. Senatorova GS, Chaychenko TV. (2012). The features of diagnostics and treatment of the metabolic syndrome among the childrenю Methodical recommendations. Kyiv. PMid:23035607

12. Startseva AI, Scherbakova MJ, Pogoda TV. (2005). The risk factors of atherosclerosis. Pediatrics. 3: 93–95.

13. Scherbakova MJ, Sinitsyn PA, Petryaykina EE. (2008). A metabolic syndrome – a type of the pediatrician. The doctor in charge of the case. 7: 40–42.

14. Scherbakova MJ, Startseva AI, Samsygina GA. (2010). The biochemical markers of atherosclerosis among the children of high-risk groups. Pediatrics and neonatology. 11: 65–69.

15. Barter PJ, Ballantyne CM, Carmena R et al. (2006). Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel. J. Intern. Med. 259(3): 247–258. https://doi.org/10.1111/j.1365-2796.2006.01616.x; PMid:16476102

16. Cali AM, Caprio S. (2008). Obesity in children and adolescents. J Clin Endocrinol Metab. 93(1): 31–36. https://doi.org/10.1210/jc.2008-1363; PMid:18987268 PMCid:PMC2585761

17. Eiland LS, Luttrell PK. (2010). Use of statins for dyslipidemia in the pediatric population. JPPT. 15(3): 160–172. PMid:22477808 PMCid:PMC3018249

18. Giald Twig, Gal Yaniv, Hagai Levine et al. (2016). Bode-Mass Indexin 2.3 Million Adolecents and Cardiovascular Deathin Adulthood. N Engl. J. Med. 374: 2430–2440. https://doi.org/10.1056/NEJMoa1503840; PMid:27074389

19. McKrindle BW. (2007). Summary of the American Heart Association’s scientifics tatement on drug Therapy of High – Risk Lipid abnormalities in childrenand adolescents. Arteioscler. Thromb. Vasc. Biol. 27: 982–985. https://doi.org/10.1161/ATVBAHA.107.143644; PMid:17442893

20. JrMeGill HC, McMahan CA, Gidding SS. (2008). Preventing heart disease in the 21st century. Implications of the Pathobiological Determinants of Atherosclerosisin Youth (PDAY) Study. Circulation. 117: 1216–1227. https://doi.org/10.1161/CIRCULATIONAHA.107.717033; PMid:18316498

21. PekKavez Rae-Ellen W, Simons-Morton DG, de Jesus JM. (2011). Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents: Summary Report. Pediatrics. 128; 5: 1085–1087.